Therefore, the CXCL12/CXCR4 axis contributes to the establishment of an appropriate microenvironment in the bone, or a “pre-metastatic niche”, for osteotropic cancers like breast, and prostate [36,37]. This evidence concerns the gene CXCL12 and cancer.